Pai.ACT: AI-powered chatbot-assisted ACT for parents of children with neurodevelopmental disorders
Official title: Artificial Intelligence-driven, Chatbot-assisted Acceptance and Commitment Therapy (Pai.ACT) for Parents of Young Children With Neurodevelopmental Disorders: A Randomised Controlled Trial
Run by Chinese University of Hong Kong · NCT06779422 · Data updated 2026-11-12
This trial tests a chatbot-guided ACT program for Cantonese-speaking parents of young children with neurodevelopmental disorders to see if it helps reduce parenting stress and improves family well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 210 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT06779422 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Cantonese-speaking parents of 2–6 year-olds with NDD (ASD, ADHD, or developmental delay) living in Hong Kong, who are comfortable using a smartphone and are not currently enrolled in other psychosocial interventions.
✕Probably not a fit
Parents with severe mental health conditions, significant cognitive/language barriers, or those already participating in other psychosocial programs may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study uses an AI-driven chatbot to deliver personalized Acceptance and Commitment Therapy strategies to primary caregivers of children aged 2–6 with neurodevelopmental disorders. It aims to address parental anxiety and depression while enhancing psychological flexibility and parenting practices. Participants are Cantonese-speaking, Hong Kong residents who live with their child, own a smartphone, and meet DSM-5-based criteria for their child’s NDD diagnosis. The intervention seeks to be scalable and accessible beyond traditional in-person formats, targeting outcomes for both parents and children. The trial is conducted under institutional oversight by Chinese University of Hong Kong with collaboration from local social welfare and service organizations.
Why it matters
Potential benefit: If successful, parents may experience reduced stress and improved mental health, potentially benefiting child development and family functioning.
How similar studies have gone: Previous studies suggest ACT-based approaches can help parents of children with developmental challenges, but virtual or AI-guided formats remain relatively novel and still require robust validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary caregivers who are Cantonese-speaking Hong Kong residents. * Parents aged ≥21 years. * Primary caregivers who adopt the responsibility of taking care of the child. * Living together with the child and having smartphone devices for daily access to the internet. * Parent's children should be with following criteria: i) Aged 2-6 years. ii) Received a primary and clinical diagnosis/suspected diagnosis of NDD as indicated in the clinical records according to the DSM-5 criteria. (e.g., ASD, ADHD, developmental delay) iii) Registered for Social Welfare Department subvented Onsite Pre-school Rehabilitation Services. Exclusion Criteria: * Parents diagnosed with severe mental illnesses. * Parents with learning, cognitive, language, communication impairments or other debilitating conditions. (e.g., hearing or vision impairment) that could impede full participation in the study) * Parents currently participating in /under the evaluation of other psychosocial, psychoeducation or parenting programmes.
Where it's running
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Yuen Yu CHONG, PhD
- Email: conniechong@cuhk.edu.hk
- Phone: (852) 3943 0665
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Nightly external trigeminal nerve stimulation to reduce ADHD symptoms in children with autism
This trial will test whether a small, nightly forehead patch that delivers external trigeminal nerve stimulation can reduce ADHD symptoms in children with autism.
-
Clown therapy to help kids with autism sit for dental visits
This study tests whether clown therapy can help children with autism sit through a dental examination more easily than conventional familiarization methods.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.